Nitin K Gupta Omer Yilmaz Mark Fisher Vijay Yajnik
10.1097/MCG.0b013e3182a4e0ec
J Clin Gastroenterol
2014 Jan;48(1):55-8.
author_manuscript
https://pubmed.ncbi.nlm.nih.gov/24045285/
Immunoconjugates / therapeutic use Immunosuppressive Agents / therapeutic use Polyendocrinopathies, Autoimmune / drug therapy
Immunoconjugates / therapeutic use Immunosuppressive Agents / therapeutic use Polyendocrinopathies, Autoimmune / drug therapy Case Reports Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Abatacept Adult Diarrhea / drug therapy Diarrhea / etiology Enterocytes / pathology Female Humans Lymphocyte Activation / drug effects Middle Aged Polyendocrinopathies, Autoimmune / physiopathology Treatment Outcome Immunoconjugates Immunosuppressive Agents Abatacept Autoimmune enteropathy
PMC4518556
24045285
Abatacept: a new treatment option for refractory adult autoimmune enteropathy
2014